These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 21676672

  • 1. [Gram-negative bacteremia in neutropenic patients with hematologic disorders. Experiences with prophylactic use of fluoroquinolones].
    Sinkó J, Cser V, Konkoly Thege M, Masszi T.
    Orv Hetil; 2011 Jul 03; 152(27):1063-7. PubMed ID: 21676672
    [Abstract] [Full Text] [Related]

  • 2. Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.
    Kern WV, Klose K, Jellen-Ritter AS, Oethinger M, Bohnert J, Kern P, Reuter S, von Baum H, Marre R.
    Eur J Clin Microbiol Infect Dis; 2005 Feb 03; 24(2):111-8. PubMed ID: 15714332
    [Abstract] [Full Text] [Related]

  • 3. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
    Ugarte-Torres A, Villasis-Keever A, Hernández-Bribiesca ME, Crespo-Solis E, Ruiz-Palacios GM, Sifuentes-Osornio J, Ponce-De-León-Garduño A.
    Rev Invest Clin; 2006 Feb 03; 58(6):547-54. PubMed ID: 17432285
    [Abstract] [Full Text] [Related]

  • 4. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O, Ljungman P, Sparrelid E, Mattsson J, Remberger M.
    Transpl Infect Dis; 2014 Feb 03; 16(1):106-14. PubMed ID: 24372809
    [Abstract] [Full Text] [Related]

  • 5. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
    Reuter S, Kern WV, Sigge A, Döhner H, Marre R, Kern P, von Baum H.
    Clin Infect Dis; 2005 Apr 15; 40(8):1087-93. PubMed ID: 15791505
    [Abstract] [Full Text] [Related]

  • 6. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M, Cumpston AD, Hobbs GR, Devetten MP, Sarwari AR, Ericson SG.
    Bone Marrow Transplant; 2007 Apr 15; 39(8):477-82. PubMed ID: 17322937
    [Abstract] [Full Text] [Related]

  • 7. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
    Chong Y, Yakushiji H, Ito Y, Kamimura T.
    Int J Infect Dis; 2011 Apr 15; 15(4):e277-81. PubMed ID: 21324723
    [Abstract] [Full Text] [Related]

  • 8. Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients.
    Bow EJ.
    Curr Opin Infect Dis; 2011 Dec 15; 24(6):545-53. PubMed ID: 22001945
    [Abstract] [Full Text] [Related]

  • 9. Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia.
    Verlinden A, Jansens H, Goossens H, van de Velde AL, Schroyens WA, Berneman ZN, Gadisseur AP.
    Eur J Haematol; 2014 Oct 15; 93(4):302-8. PubMed ID: 24750350
    [Abstract] [Full Text] [Related]

  • 10. Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients.
    Cruciani M, Malena M, Bosco O, Nardi S, Serpelloni G, Mengoli C.
    J Clin Oncol; 2003 Nov 15; 21(22):4127-37. PubMed ID: 14615441
    [Abstract] [Full Text] [Related]

  • 11. A single-center evaluation of the risk for colonization or bacteremia with piperacillin-tazobactam- and cefepime-resistant bacteria in patients with acute leukemia receiving fluoroquinolone prophylaxis.
    Nguyen AD, Heil EL, Patel NK, Duffy A, Gilmore S.
    J Oncol Pharm Pract; 2016 Apr 15; 22(2):303-7. PubMed ID: 25567517
    [Abstract] [Full Text] [Related]

  • 12. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
    Busca A, Cavecchia I, Locatelli F, D'Ardia S, De Rosa FG, Marmont F, Ciccone G, Baldi I, Serra R, Gaido E, Falda M.
    Transpl Infect Dis; 2012 Feb 15; 14(1):40-8. PubMed ID: 21599817
    [Abstract] [Full Text] [Related]

  • 13. Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999-2002.
    Kern WV, Steib-Bauert M, de With K, Reuter S, Bertz H, Frank U, von Baum H.
    J Antimicrob Chemother; 2005 Jan 15; 55(1):57-60. PubMed ID: 15574472
    [Abstract] [Full Text] [Related]

  • 14. [Neutropenia and sepsis in hematologic patients].
    Egyed M, Kollár B, Karádi E, Rajnics P, Kocsondi L, Rumi G.
    Orv Hetil; 2006 Oct 22; 147(42):2031-3. PubMed ID: 17165603
    [Abstract] [Full Text] [Related]

  • 15. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.
    Cattaneo C, Quaresmini G, Casari S, Capucci MA, Micheletti M, Borlenghi E, Signorini L, Re A, Carosi G, Rossi G.
    J Antimicrob Chemother; 2008 Mar 22; 61(3):721-8. PubMed ID: 18218645
    [Abstract] [Full Text] [Related]

  • 16. Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres.
    Castagnola E, Haupt R, Micozzi A, Caviglia I, Testi AM, Giona F, Parodi S, Girmenia C.
    Clin Microbiol Infect; 2005 Jun 22; 11(6):505-7. PubMed ID: 15882204
    [Abstract] [Full Text] [Related]

  • 17. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
    Gudiol C, Bodro M, Simonetti A, Tubau F, González-Barca E, Cisnal M, Domingo-Domenech E, Jiménez L, Carratalà J.
    Clin Microbiol Infect; 2013 May 22; 19(5):474-9. PubMed ID: 22524597
    [Abstract] [Full Text] [Related]

  • 18. Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization.
    Brigmon MM, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN.
    Clin Microbiol Infect; 2015 Sep 22; 21(9):843-9. PubMed ID: 26003282
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.
    Averbuch D, Tridello G, Hoek J, Mikulska M, Akan H, Yanez San Segundo L, Pabst T, Özçelik T, Klyasova G, Donnini I, Wu D, Gülbas Z, Zuckerman T, Botelho de Sousa A, Beguin Y, Xhaard A, Bachy E, Ljungman P, de la Camara R, Rascon J, Ruiz Camps I, Vitek A, Patriarca F, Cudillo L, Vrhovac R, Shaw PJ, Wolfs T, O'Brien T, Avni B, Silling G, Al Sabty F, Graphakos S, Sankelo M, Sengeloev H, Pillai S, Matthes S, Melanthiou F, Iacobelli S, Styczynski J, Engelhard D, Cesaro S.
    Clin Infect Dis; 2017 Nov 13; 65(11):1819-1828. PubMed ID: 29020364
    [Abstract] [Full Text] [Related]

  • 20. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients.
    Shi SH, Kong HS, Xu J, Zhang WJ, Jia CK, Wang WL, Shen Y, Zhang M, Zheng SS.
    Transpl Infect Dis; 2009 Oct 13; 11(5):405-12. PubMed ID: 19638006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.